@article{Hill2007,
author = {Hill KK, Smith TJ, Helma CH, Ticknor LO, Foley BT, Svensson RT, Brown JL, Johnson EA, Smith LA, Okinaka RT, Jackson PJ, Marks JD.},
title = {Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.},
journal = {J Bacteriol.},
year = {2007},
doi = {10.1128/JB.01180-06},
pmid = {17114256}
}

@article{Whelan1992,
author = {Whelan SM, Elmore MJ, Bodsworth NJ, Brehm JK, Atkinson T, Minton NP.},
title = {Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence.},
journal = {Appl Environ Microbiol.},
year = {1992},
doi = {},
pmid = {1514783}
}

@article{Berntsson2013,
author = {Berntsson RP, Peng L, Dong M, Stenmark P.},
title = {Structure of dual receptor binding to botulinum neurotoxin B.},
journal = {Nat Commun},
year = {2013},
doi = {10.1038/ncomms3058},
pmid = {23807078}
}

@article{Elliott2017,
author = {Elliott M, Maignel J, Liu SM, Favre-Guilmard C, Mir I, Farrow P, Hornby F, Marlin S, Palan S, Beard M, Krupp J.},
title = {Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems.},
journal = {PLoS ONE},
year = {2017},
doi = {10.1371/journal.pone.0185628},
pmid = {28982136}
}

@article{Tao2017,
author = {Tao L, Peng L, Berntsson RP, Liu SM, Park S, Yu F, Boone C, Palan S, Beard M, Chabrier PE, Stenmark P, Krupp J, Dong M.},
title = {Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors.},
journal = {Nat Commun},
year = {2017},
doi = {10.1038/s41467-017-00064-y},
pmid = {28674381}
}

@article{Rust2017,
author = {Rust A, Doran C, Hart R, Binz T, Stickings P, Sesardic D, Peden AA, Davletov B.},
title = {A Cell Line for Detection of Botulinum Neurotoxin Type B.},
journal = {Front Pharmacol},
year = {2017},
doi = {10.3389/fphar.2017.00796},
pmid = {29170639}
}

@article{Elliott2019,
author = {Elliott M, Favre-Guilmard C, Liu SM, Maignel J, Masuyer G, Beard M, Boone C, Carré D, Kalinichev M, Lezmi S, Mir I, Nicoleau C, Palan S, Perier C, Raban E, Zhang S, Dong M, Stenmark P, Krupp J.},
title = {Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.},
journal = {Sci Adv},
year = {2019},
doi = {10.1126/sciadv.aau7196},
pmid = {30746458}
}

@article{Flores2019,
author = {Flores A, Ramirez-Franco J, Desplantes R, Debreux K, Ferracci G, Wernert F, Blanchard MP, Maulet Y, Youssouf F, Sangiardi M, Iborra C, Popoff MR, Seagar M, Fantini J, Lévêque C, El Far O.},
title = {Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B.},
journal = {Proc. Natl. Acad. Sci. U.S.A.},
year = {2019},
doi = {201908051},
pmid = {31431523}
}

@article{Davies2020,
author = {Davies JR, Masuyer G, Stenmark P.},
title = {Structural and Biochemical Characterization of Botulinum Neurotoxin Subtype B2 Binding to Its Receptors.},
journal = {Toxins (Basel)},
year = {2020},
doi = {E603},
pmid = {32957706}
}